Scientists can peer into cells to get a limited view of their activity using microscopes and other tools. However, cells and ...
An exploratory study shows that combining short-term topical microdosing with gene-expression profiling can detect early drug ...
Scribe expects to initiate a first-in-human hypercholesterolemia study in mid-2026 with STX-1150, its lead cardiometabolic assetSTX-1150 is designed to deliver durable therapeutic LDL-C lowering with ...
Project LiBRha aims to improve pediatric STS diagnosis and treatment through comprehensive molecular testing and liquid biopsy integration. The initiative involves 18 centers and partnerships with the ...
A research team has uncovered and reconstructed the complete biosynthetic pathway of polyphyllin II—a potent anticancer ...
Complex human diseases—such as cancer, neurodegenerative disorders, autoimmune conditions, cardiometabolic disease, and chronic inflammatory syndromes—arise ...
Universal rRNA depletion can put the power of RNA-seq at the disposal of researchers studying any organism, from dangerous pathogens to vital plant crops. The RNA sequencing (RNA-seq) revolution is ...
Transcriptome-based NGS outperforms traditional viral testing with superior sensitivity, detecting viruses including novel ...
The market for microbiome sample preparation technology presents opportunities driven by demand for personalized medicine, ...
According to Nova One Advisor, the global next-generation sequencing market size is calculated at USD 17.37 billion in 2026 ...
National security, unlocked. Each Thursday, host Mary Louise Kelly and a team of NPR correspondents discuss the biggest national security news of the week. With decades of reporting from battlefields ...